These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16724487)

  • 1. Testing for crossover of two hazard functions using Gail and Simon's method.
    Chen YH; Liu GH
    J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative risk estimation and inference using a generalized logrank statistic.
    Mehrotra DV; Roth AJ
    Stat Med; 2001 Jul; 20(14):2099-113. PubMed ID: 11439424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
    Liu M; Lu W; Shao Y
    Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
    Tu D
    Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim analysis on survival data: its potential bias and how to repair it.
    van Houwelingen HC; van de Velde CJ; Stijnen T
    Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible approach to the crossing hazards problem.
    Muggeo VM; Tagliavia M
    Stat Med; 2010 Aug; 29(18):1947-57. PubMed ID: 20680987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate event.
    Bebchuk JD; Betensky RA
    Stat Med; 2005 Feb; 24(3):359-78. PubMed ID: 15568187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible modeling of the effects of continuous prognostic factors in relative survival.
    Mahboubi A; Abrahamowicz M; Giorgi R; Binquet C; Bonithon-Kopp C; Quantin C
    Stat Med; 2011 May; 30(12):1351-65. PubMed ID: 21432891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating survival times to simulate Cox proportional hazards models.
    Bender R; Augustin T; Blettner M
    Stat Med; 2005 Jun; 24(11):1713-23. PubMed ID: 15724232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with the proportional hazards assumption when using the proportional hazards model with a single independent variable.
    Shibata A; Hamajima N; Tamakoshi A; Suzuki S; Sasaki R; Aoki K
    Jpn J Clin Oncol; 1989 Sep; 19(3):195-201. PubMed ID: 2810819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative interactions in multifactor studies.
    Russek-Cohen E; Simon RM
    Biometrics; 1993 Jun; 49(2):467-77. PubMed ID: 8369382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reformulating the hazard ratio to enhance communication with clinical investigators.
    Moser BK; McCann MH
    Clin Trials; 2008; 5(3):248-52. PubMed ID: 18559414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
    Lin CC; Hsu CH; Huang CY; Tsai YC; Huang KH; Cheng AL; Pu YS
    Urology; 2007 Mar; 69(3):479-84. PubMed ID: 17382149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple test for independent censoring under the proportional hazards model.
    Lee SY; Wolfe RA
    Biometrics; 1998 Sep; 54(3):1176-82. PubMed ID: 9840972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-rank hazard regression for modelling non-proportional hazards.
    Perperoglou A; le Cessie S; van Houwelingen HC
    Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequential testing approach to detecting multiple change points in the proportional hazards model.
    He P; Fang L; Su Z
    Stat Med; 2013 Mar; 32(7):1239-45. PubMed ID: 22933339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.